top of page
Akamis Bio Header Image

Publications

Actin-resistant DNAse I Expression From Oncolytic Adenovirus Enadenotucirev Enhances Its Intratumoral Spread and Reduces Tumor Growth

Tedcastle A, Illingworth S, Brown A, Seymour LW, Fisher KD. Mol Ther. 2016;24:796–804

Click Here for Full Text

A phase 1 trial of the safety, tolerability and biological effects of intravenous Enadenotucirev, a novel oncolytic virus, in combination with chemoradiotherapy in locally advanced rectal cancer (CEDAR)

Séan M. O’Cathail, Steven Davis, Jane Holmes, Richard Brown, Kerry Fisher, Leonard Seymour, Richard Adams, James Good, David Sebag-Montefiore, Tim Maughan and Maria A. Hawkins*
Radiation Oncology (2020) 15:151

Click Here for Full Text

Viral vanguard: Designing cancer-killing viruses to chase metastatic tumors

Chakradhar S. Nature Medicine 23, 652–655 (2017)

Click Here for Full Text
Cell Therapy Paper Anchor
bottom of page